KALA BIO, Inc. (KALA) stock
KALANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 5/30
$3.26−0.17 (-4.96%)
Close on Nov 18, 2026Market cap $63.05MP/E –Yield –
Kala Bio operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Kala Bio's operating cash flow for the twelve months ending Jun 30, 2026 was -$19.86M. For fiscal 2025 it was -$31.99M. The highest annual figure on record is -$15.09M in fiscal 2015.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$31.99M | – |
| FY2024 | Dec 31, 2024 | -$29.38M | – |
| FY2023 | Dec 31, 2023 | -$27.93M | – |
| FY2022 | Dec 31, 2022 | -$78.91M | – |
| FY2021 | Dec 31, 2021 | -$108.24M | – |
| FY2020 | Dec 31, 2020 | -$90.69M | – |
| FY2019 | Dec 31, 2019 | -$92.72M | – |
| FY2018 | Dec 31, 2018 | -$54.12M | – |
| FY2017 | Dec 31, 2017 | -$34.10M | – |
| FY2016 | Dec 31, 2016 | -$27.35M | – |
| FY2015 | Dec 31, 2015 | -$15.09M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.54M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.90M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.56M | – |
| Q3 FY2025 | Sep 30, 2025 | -$10.88M | – |
| Q2 FY2025 | Jun 30, 2025 | -$16.56M | – |
| Q1 FY2025 | Mar 31, 2025 | -$8.82M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.60M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.73M | – |
| Q2 FY2024 | Jun 30, 2024 | -$9.22M | – |
| Q1 FY2024 | Mar 31, 2024 | -$10.84M | – |
| Q4 FY2023 | Dec 31, 2023 | -$7.70M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.95M | – |
| Q2 FY2023 | Jun 30, 2023 | -$7.60M | – |
| Q1 FY2023 | Mar 31, 2023 | -$9.68M | – |
| Q4 FY2022 | Dec 31, 2022 | -$13.74M | – |
| Q3 FY2022 | Sep 30, 2022 | -$15.67M | – |
| Q2 FY2022 | Jun 30, 2022 | -$25.42M | – |
| Q1 FY2022 | Mar 31, 2022 | -$24.09M | – |
| Q4 FY2021 | Dec 31, 2021 | -$27.90M | – |
| Q3 FY2021 | Sep 30, 2021 | -$26.08M | – |
| Q2 FY2021 | Jun 30, 2021 | -$21.61M | – |
| Q1 FY2021 | Mar 31, 2021 | -$32.64M | – |
| Q4 FY2020 | Dec 31, 2020 | -$25.92M | – |
| Q3 FY2020 | Sep 30, 2020 | -$25.64M | – |
| Q2 FY2020 | Jun 30, 2020 | -$19.25M | – |
| Q1 FY2020 | Mar 31, 2020 | -$19.88M | – |
| Q4 FY2019 | Dec 31, 2019 | -$18.21M | – |
| Q3 FY2019 | Sep 30, 2019 | -$22.91M | – |
| Q2 FY2019 | Jun 30, 2019 | -$20.43M | – |
| Q1 FY2019 | Mar 31, 2019 | -$31.17M | – |
| Q4 FY2018 | Dec 31, 2018 | -$15.99M | – |
| Q3 FY2018 | Sep 30, 2018 | -$16.21M | – |
| Q2 FY2018 | Jun 30, 2018 | -$9.21M | – |
| Q1 FY2018 | Mar 31, 2018 | -$12.71M | – |
| Q4 FY2017 | Dec 31, 2017 | -$6.56M | – |
| Q3 FY2017 | Sep 30, 2017 | -$9.33M | – |
| Q2 FY2017 | Jun 30, 2017 | -$8.85M | – |
| Q1 FY2017 | Mar 31, 2017 | -$9.36M | – |
| Q4 FY2016 | Dec 31, 2016 | -$7.33M | – |
| Q3 FY2016 | Sep 30, 2016 | -$8.15M | – |
See a number that looks wrong?